New research evaluates clinical trials investigating post-acute COVID-19 syndrome treatment
Por um escritor misterioso
Descrição
In a recent article published in Clinical Microbiology and Infection, researchers reviewed all registered trials currently investigating potential treatment options for post-acute coronavirus disease 2019 (COVID-19) syndrome (PACS).
A multi-omics based anti-inflammatory immune signature characterizes long COVID-19 syndrome - ScienceDirect
CDC Museum COVID-19 Timeline, David J. Sencer CDC Museum
Long COVID NIH COVID-19 Research
JCM, Free Full-Text
Phase 3 Safety and Efficacy of AZD1222 (ChAdOx1 nCoV-19) Covid-19 Vaccine
Clinical trials of hydroxychloroquine in COVID19 outpatients reported as safe
Frontiers Unraveling the Mystery Surrounding Post-Acute Sequelae of COVID- 19
Frontiers Long COVID or Post-acute Sequelae of COVID-19 (PASC): An Overview of Biological Factors That May Contribute to Persistent Symptoms
New research evaluates clinical trials investigating post-acute COVID-19 syndrome treatment
Annual Report to the Nation Part 2 pandemic cancer diagnoses - NCI
Rationale, Design and Baseline Characteristics of the PARAGLIDE-HF Trial: Sacubitril/Valsartan vs Valsartan in HFmrEF and HFpEF With a Worsening Heart Failure Event - Journal of Cardiac Failure
